Table 2.

Epitope mapping of CD66/CEACAM Mabs

Mabδ N (CEACAM6 1-59 aa)*N (CEACAM6 1-122 aa)*CEA CEACAM1,3,6,8*CEACAM1 N-domain bindingCEACAM1-1-FcCEACAM1-3-FcCEACAM1-4-FcNCAM(D1-5)-Fc/
Muc 18-Fc
26H7 − − CEACAM1 1.498 ± 0.127 1.672 ± 0.068 1.659 ± 0.167 0.083 ± 0.003 
5F4 − − CEACAM1 1.774 ± 0.024 1.933 ± 0.090 1.931 ± 0.044 0.082 ± 0.001 
TEC-11 − − CEACAM1 − 0.205 ± 0.005 0.188 ± 0.004 1.298 ± 0.121 0.191 ± 0.004 
12-140-4 nd nd CEACAM1 CEA 1.560 ± 0.087 1.628 ± 0.253 1.731 ± 0.085 0.257 ± 0.018 
4/3/17,2-153 − CEACAM1 CEA 2.118 ± 0.106 2.178 ± 0.155 2.444 ± 0.101 0.416 ± 0.066 
b 7.8.5 − − CEA − nd  0.268 ± 0.019 0.267 ± 0.034 0.252 ± 0.007 
YG-C35D6 − − CEACAM6 CEA − 0.360 ± 0.033 0.339 ± 0.040 0.356 ± 0.030 0.284 ± 0.010 
COL-4 nd nd CEACAM1,3 CEA 2.396 ± 0.60 2.319 ± 0.023 2.421 ± 0.122 0.310 ± 0.006 
F36-54 − − CEACAM1,6 CEA − 0.187 ± 0.011 0.834 ± 0.031 0.999 ± 0.279 0.178 ± 0.016 
34B1 nd nd CEACAM1,3,6 CEA 1.364 ± 0.117 1.507 ± 0.050 1.460 ± 0.089 0.800 ± 0.005 
YG-C28F2 nd nd CEACAM1,3,6 CEA 1.952 ± 0.275 1.872 ± 0.140 2.035 ± 0.164 0.271 ± 0.004 
D14HD11 CEACAM1,3,6 CEA 2.248 ± 0.168 2.175 ± 0.144 2.294 ± 0.163 0.221 ± 0.008 
b18.7.7 CEACAM1,3,6 CEA 1.795 ± 0.277 2.073 ± 0.346 1.822 ± 0.147 0.201 ± 0.058 
D11-AD11 CEACAM1,3,6 CEA 2.248 ± 0.168 2.175 ± 0.144 2.294 ± 0.163 0.221 ± 0.008 
HEA 81 CEACAM1,3,6 CEA 0.505 ± 0.120 0.577 ± 0.083 0.379 ± 0.062 0.206 ± 0.005 
B1.12-153 − CEACAM1,3,6 CEA 0.870 ± 0.046 0.890 ± 0.126 1.051 ± 0.125 0.285 ± 0.002 
CLB-gran-102-155 − CEACAM1,3,6 CEA 1.946 ± 0.389 2.071 ± 0.055 1.944 ± 0.086 0.206 ± 0.017 
F34-187,2-153 − CEACAM1,3,6 CEA 2.019 ± 0.284 2.189 ± 0.148 2.135 ± 0.263 0.205 ± 0.006 
T84.1,2-155 − CEACAM1,3,6 CEA 1.572 ± 0.138 1.701 ± 0.238 1.488 ± 0.317 0.235 ± 0.025 
B6.2 nd nd CEACAM1,3,6 CEA 1.913 ± 0.469 1.972 ± 0.335 2.325 ± 0.246 0.365 ± 0.039 
B1.13 nd nd CEACAM1,3,6 CEA 1.660 ± 0.050 1.698 ± 0.213 1.808 ± 0.194 0.253 ± 0.018 
YG-C94G7 − − CEACAM1,6,8 CEA − 0.342 ± 0.037 1.469 ± 0.227 1.458 ± 0.062 0.279 ± 0.023 
12-140-5 − − CEACAM1,6,8 CEA − 0.444 ± 0.055 2.432 ± 0.033 2.357 ± 0.062 0.475 ± 0.051 
TET-2 − − CEACAM1,6,8 CEA − 0.327 ± 0.023 2.041 ± 0.061 2.198 ± 0.262 0.289 ± 0.023 
mIgG1 − − − − 0.147 ± 0.003 0.147 ± 0.003 0.150 ± 0.008 0.145 ± 0.005 
mIgG2a − − − − 0.142 ± 0.002 0.135 ± 0.002 0.200 ± 0.010 0.206 ± 0.017 
mIgG2b − − − − 0.199 ± 0.010 0.220 ± 0.019 0.144 ± 0.006 0.145 ± 0.011 
mIgG1 − − − − 0.196 ± 0.016 0.223 ± 0.037 0.206 ± 0.008 0.184 ± 0.020 
mIgG2a − − − − 0.188 ± 0.029 0.196 ± 0.004 0.201 ± 0.057 0.170 ± 0.009 
mIgG2b − − − − 0.265 ± 0.111 0.156 ± 0.014 0.168 ± 0.012 0.166 ± 0.021 
mIgM − − − − 0.171 ± 0.026 0.193 ± 0.026 0.201 ± 0.049 0.178 ± 0.028 
Mabδ N (CEACAM6 1-59 aa)*N (CEACAM6 1-122 aa)*CEA CEACAM1,3,6,8*CEACAM1 N-domain bindingCEACAM1-1-FcCEACAM1-3-FcCEACAM1-4-FcNCAM(D1-5)-Fc/
Muc 18-Fc
26H7 − − CEACAM1 1.498 ± 0.127 1.672 ± 0.068 1.659 ± 0.167 0.083 ± 0.003 
5F4 − − CEACAM1 1.774 ± 0.024 1.933 ± 0.090 1.931 ± 0.044 0.082 ± 0.001 
TEC-11 − − CEACAM1 − 0.205 ± 0.005 0.188 ± 0.004 1.298 ± 0.121 0.191 ± 0.004 
12-140-4 nd nd CEACAM1 CEA 1.560 ± 0.087 1.628 ± 0.253 1.731 ± 0.085 0.257 ± 0.018 
4/3/17,2-153 − CEACAM1 CEA 2.118 ± 0.106 2.178 ± 0.155 2.444 ± 0.101 0.416 ± 0.066 
b 7.8.5 − − CEA − nd  0.268 ± 0.019 0.267 ± 0.034 0.252 ± 0.007 
YG-C35D6 − − CEACAM6 CEA − 0.360 ± 0.033 0.339 ± 0.040 0.356 ± 0.030 0.284 ± 0.010 
COL-4 nd nd CEACAM1,3 CEA 2.396 ± 0.60 2.319 ± 0.023 2.421 ± 0.122 0.310 ± 0.006 
F36-54 − − CEACAM1,6 CEA − 0.187 ± 0.011 0.834 ± 0.031 0.999 ± 0.279 0.178 ± 0.016 
34B1 nd nd CEACAM1,3,6 CEA 1.364 ± 0.117 1.507 ± 0.050 1.460 ± 0.089 0.800 ± 0.005 
YG-C28F2 nd nd CEACAM1,3,6 CEA 1.952 ± 0.275 1.872 ± 0.140 2.035 ± 0.164 0.271 ± 0.004 
D14HD11 CEACAM1,3,6 CEA 2.248 ± 0.168 2.175 ± 0.144 2.294 ± 0.163 0.221 ± 0.008 
b18.7.7 CEACAM1,3,6 CEA 1.795 ± 0.277 2.073 ± 0.346 1.822 ± 0.147 0.201 ± 0.058 
D11-AD11 CEACAM1,3,6 CEA 2.248 ± 0.168 2.175 ± 0.144 2.294 ± 0.163 0.221 ± 0.008 
HEA 81 CEACAM1,3,6 CEA 0.505 ± 0.120 0.577 ± 0.083 0.379 ± 0.062 0.206 ± 0.005 
B1.12-153 − CEACAM1,3,6 CEA 0.870 ± 0.046 0.890 ± 0.126 1.051 ± 0.125 0.285 ± 0.002 
CLB-gran-102-155 − CEACAM1,3,6 CEA 1.946 ± 0.389 2.071 ± 0.055 1.944 ± 0.086 0.206 ± 0.017 
F34-187,2-153 − CEACAM1,3,6 CEA 2.019 ± 0.284 2.189 ± 0.148 2.135 ± 0.263 0.205 ± 0.006 
T84.1,2-155 − CEACAM1,3,6 CEA 1.572 ± 0.138 1.701 ± 0.238 1.488 ± 0.317 0.235 ± 0.025 
B6.2 nd nd CEACAM1,3,6 CEA 1.913 ± 0.469 1.972 ± 0.335 2.325 ± 0.246 0.365 ± 0.039 
B1.13 nd nd CEACAM1,3,6 CEA 1.660 ± 0.050 1.698 ± 0.213 1.808 ± 0.194 0.253 ± 0.018 
YG-C94G7 − − CEACAM1,6,8 CEA − 0.342 ± 0.037 1.469 ± 0.227 1.458 ± 0.062 0.279 ± 0.023 
12-140-5 − − CEACAM1,6,8 CEA − 0.444 ± 0.055 2.432 ± 0.033 2.357 ± 0.062 0.475 ± 0.051 
TET-2 − − CEACAM1,6,8 CEA − 0.327 ± 0.023 2.041 ± 0.061 2.198 ± 0.262 0.289 ± 0.023 
mIgG1 − − − − 0.147 ± 0.003 0.147 ± 0.003 0.150 ± 0.008 0.145 ± 0.005 
mIgG2a − − − − 0.142 ± 0.002 0.135 ± 0.002 0.200 ± 0.010 0.206 ± 0.017 
mIgG2b − − − − 0.199 ± 0.010 0.220 ± 0.019 0.144 ± 0.006 0.145 ± 0.011 
mIgG1 − − − − 0.196 ± 0.016 0.223 ± 0.037 0.206 ± 0.008 0.184 ± 0.020 
mIgG2a − − − − 0.188 ± 0.029 0.196 ± 0.004 0.201 ± 0.057 0.170 ± 0.009 
mIgG2b − − − − 0.265 ± 0.111 0.156 ± 0.014 0.168 ± 0.012 0.166 ± 0.021 
mIgM − − − − 0.171 ± 0.026 0.193 ± 0.026 0.201 ± 0.049 0.178 ± 0.028 

+ indicates positive; −, nonreactive or negative; nd, not determined.

*

Summary from the Boston and Osaka Leucocyte Culture Conferences or after testing by flow cytometry on HeLa-CEA, CEACAM3L, CEACAM6, CEACAM8, and CHO-CEACAM1-4L, -4S and -1S.

Muc 18-Fc used in place of NCAM-Fc as a negative control; N domain covers 1-180 aa of CEACAM1-4L; δ N domain of CEACAM6 covers 1-59 aa; N domain of CEACAM6 covers 1-122 aa.

Mabs to the N-terminal domain that cross-block the binding of 125I-labeled 12-140-4 to CEACAM1 or CEA transfectants indicating similar or closely linked epitopes; other N-domain Mabs were not analyzed in cross-blocking experiments.

F2-153

Does not cross-block CLB-gran/10.

F2-155

Cross-blocks CLB-gran/10.

Close Modal

or Create an Account

Close Modal
Close Modal